Brave Asset Management’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Brave Asset Management’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-600	Closed	–	–	450
2015 Q4	$0	Hold	600	–	–	﹤0.01%	455
2015 Q3	$0	Hold	600	–	–	﹤0.01%	456
2015 Q2	$1K	Hold	600	–	–	﹤0.01%	432
2015 Q1	$2K	Hold	600	–	–	﹤0.01%	418
2014 Q4	$3K	Hold	600	–	–	﹤0.01%	415
2014 Q3	$4K	Hold	600	–	–	﹤0.01%	410
2014 Q2	$9K	Buy	+600	New	+$10.4K	0.01%	380

Other funds holding RCPI

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brave Asset Management's RCPI Position: Q1 2016 in Review

Brave Asset Management sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q1 2016, closing a stake of 600 shares.

Brave Asset Management first reported a position in RCPI in Q2 2014 and held it in 7 quarters. The position peaked at $9K in Q2 2014. 3 funds tracked by Wall St. Rank hold RCPI as of Q1 2016.

Brave Asset Management reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
Brave Asset Management sold 600 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q1 2016.
Brave Asset Management first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 7 quarters.
Brave Asset Management's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $9K in Q2 2014.
3 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q1 2016.

Based on Brave Asset Management's 13F filing for Q1 2016, filed 12 May 2016.